Sentinel node localization in breast cancer

被引:42
作者
Glass, EC
Essner, R
Giuliano, AE
机构
[1] St Johns Hlth Ctr, Dept Nucl Med, Santa Monica, CA 90404 USA
[2] John Wayne Canc Inst, Santa Monica, CA USA
关键词
D O I
10.1016/S0001-2998(99)80030-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The status of the axillary nodes is the strongest known prognostic variable in patients with early breast cancer, and is routinely used in planning postoperative therapy. Conventional axillary lymph node dissection is limited by sampling error and potential morbidity. Sentinel node techniques have revolutionized the management of axillary nodes. Accurate identification and focused histologic evaluation of the sentinel node allow accurate prediction of the tumor status of other axillary nodes, thereby avoiding the morbidity and expense of a complete axillary dissection in node-negative patients, Radiotracer techniques play an important role in the preoperative and intraoperative localization of the sentinel nodes. Optimal localization of the sentinel node requires the use of both preoperative lymphoscintigraphy and intraoperative radiosensitive probes, Lymphoscintigraphy also identifies patients with lymphatic drainage to sites other than the axilla, thereby allowing more appropriate treatment and follow-up in this subset of patients. Procedures for localizing sentinel nodes require an understanding of the kinetics of the radiopharmaceuticals or other tracers used and the detection devices employed in each institution. Both surgical and nuclear medicine personnel should understand these principles, and close cooperation between surgeons, nuclear medicine physicians, and pathologists is essential for the application of sentinel node techniques. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 82 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]   Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data [J].
Arriagada, R ;
Le, MG ;
Rochard, F ;
Contesso, G .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1558-1564
[3]   LYMPH-FLOW FROM MURINE FOOTPAD TUMORS BEFORE AND AFTER SUBLETHAL HYPERTHERMIA [J].
AVERY, M ;
NATHANSON, SD ;
HETZEL, FW .
RADIATION RESEARCH, 1992, 132 (01) :50-53
[4]   CUTANEOUS LYMPHOSCINTIGRAPHY IN MALIGNANT-MELANOMA [J].
BENNETT, LR ;
LAGO, G .
SEMINARS IN NUCLEAR MEDICINE, 1983, 13 (01) :61-69
[5]   PARTICLE SIZING AND BIOKINETICS OF INTERSTITIAL LYMPHOSCINTIGRAPHIC AGENTS [J].
BERGQVIST, L ;
STRAND, SE ;
PERSSON, BRR .
SEMINARS IN NUCLEAR MEDICINE, 1983, 13 (01) :9-19
[6]  
Blichert-Toft M, 1992, J Natl Cancer Inst Monogr, P19
[7]   Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection [J].
Borgstein, P ;
Pijpers, R ;
Comans, EF ;
van Diest, PJ ;
Boom, RP ;
Meijer, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :275-283
[8]   Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients [J].
Bostick, PJ ;
Chatterjee, S ;
Chi, DD ;
Huynh, KT ;
Giuliano, AE ;
Cote, R ;
Hoon, DSB .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2632-2640
[9]   RADIATION-DOSE ESTIMATES FOR INTERSTITIAL RADIOCOLLOID LYMPHOSCINTIGRAPHY [J].
BRONSKILL, MJ .
SEMINARS IN NUCLEAR MEDICINE, 1983, 13 (01) :20-25
[10]  
CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO